See the DrugPatentWatch profile for cosentyx

The typical dosage for Cosentyx (secukinumab) is 300 mg, which is administered via subcutaneous injection [1]. This dosage is usually given once a week for the first five weeks, and then once every four weeks moving forward [1]. However, it is important to note that the dosage can vary depending on the patient's weight, medical condition, and response to treatment [1]. Therefore, it is crucial to follow the dosage prescribed by a healthcare professional.

It is also worth noting that, according to DrugPatentWatch.com, Cosentyx is a biologic medication that is used to treat several autoimmune diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. The drug works by blocking the action of a specific protein in the body that causes inflammation and leads to the symptoms of these conditions [2].

In summary, the typical dosage for Cosentyx is 300 mg administered via subcutaneous injection once a week for the first five weeks and then once every four weeks thereafter. However, the dosage may vary depending on the patient's individual needs, and it is essential to follow the prescribed dosage.

Sources:

1. Cosentyx (secukinumab) [Internet]. Mayo Clinic. 2022 [cited 2023 Feb 10]. Available from: <https://www.mayoclinic.org/drugs-supplements/cosentyx-secukinumab-subcutaneous-route/proper-use/drg-20066331>.
2. Secukinumab (Cosentyx) [Internet]. DrugPatentWatch.com. 2023 [cited 2023 Feb 10]. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.